39.08 -0.49 (-1.20%)
ALXN
Stock Details
Last Trade:39.08 Change:-0.49 (-1.20%) Prev Close:39.57 Open: 40.72 Days Range:38.56 – 40.72 52 Week Range: 28.16 - 95.91 Volume:729629 P/E: 66.24EPS:0.59
View AllRecent Alerts 07/03/09
Recent Alert on 06/11/09 at 3:55pm
Piper Jaffray Resumes Coverage on Alexion (ALXN) with a Buy; Warrants Premium to Peer Group
Piper Jaffray Resumes Coverage on Alexion (ALXN) with a Buy; Warrants Premium to Peer Group
Piper Jaffray & Co. resumes coverage on Alexion (Nasdaq: ALXN) with a Buy rating. Price target $47. Piper analyst says, "Mid-Cap is Where It's At. Our investment thesis for this early recovery is that profitable, mid-cap biotech names with... Read More
Recent Alert on 06/08/09 at 8:13am
Alexion Pharma's (ALXN) Soliris(R) Receives Positive Opinion from Clinical Investigators
Alexion Pharma's (ALXN) Soliris(R) Receives Positive Opinion from Clinical Investigators
Recent Alert on 04/23/09 at 8:30am
Alexion Pharma (ALXN) Reports Mixed Q1 Earnings; Reaffirms Guidance
Alexion Pharma (ALXN) Reports Mixed Q1 Earnings; Reaffirms Guidance
Recent Alert on 04/23/09 at 8:30am
Alexion Pharma (ALXN) Reports Mixed Q1 Earnings; Reaffirms Guidance
Alexion Pharma (ALXN) Reports Mixed Q1 Earnings; Reaffirms Guidance
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 06/28/09 at 7:47am
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
Blog Posts on 06/19/09 at 7:14am
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline